Journal article
Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes
- Abstract:
-
Background
The Scottish Medicines Consortium evaluates new drugs for use in the National Health Service in Scotland. Reforms in 2014 to their evaluation process aimed to increase patient access to new drugs for end-of-life or rare conditions; the changes include additional steps in the process to gain further information from patients and clinicians, and for revised commercial agreements. This study examines the extent of any impact of the reforms on funding decisions.
Me...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Cancer Research UK
More from this funder
Bibliographic Details
- Publisher:
- BioMed Central Publisher's website
- Journal:
- BMC Health Services Research Journal website
- Volume:
- 17
- Pages:
- 613
- Publication date:
- 2017-08-01
- Acceptance date:
- 2017-08-21
- DOI:
- ISSN:
-
1472-6963
Item Description
- Keywords:
- Pubs id:
-
pubs:725631
- UUID:
-
uuid:06afb578-5f24-4197-9ed0-de0b46bc0ed1
- Local pid:
- pubs:725631
- Deposit date:
- 2017-09-05
Terms of use
- Copyright holder:
- Morrell et al
- Copyright date:
- 2017
- Notes:
- © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record